GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". High institutional ownership can be a signal of strong market trust in this company. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. (Add your “underperform” vote.). Company Summary x. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. Guardant Health employs 622 workers across the globe. View our earnings forecast for Guardant Health. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Since then, GH stock has increased by 94.2% and is now trading at $122.26. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Follow My #1 Rule Instead. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. When autocomplete results are available use up and down arrows to review and enter to select. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Shares of GH can be purchased through any online brokerage account. Guardant Health has a P/B Ratio of 14.38. Guardant Health has received a consensus rating of Buy. $124.09. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Learn everything you need to know about successful options trading with this three-part video course. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … He’s agreed to share his secret with a small group of investors. Their forecasts range from $100.00 to $150.00. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. (Add your “outperform” vote. Your current $100 investment may be up to $180.14 in 2025. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Fundamental company data provided by Morningstar and Zacks Investment Research. Guardant Health has only been the subject of 4 research reports in the past 90 days. See what's happening in the market right now with MarketBeat's real-time news feed. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. Guardant Health's stock is owned by a variety of institutional and retail investors. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Add to Watchlist. Looking for new stock ideas? Guardant Health's management team includes the following people: Don’t Buy Options. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Identify stocks that meet your criteria using seven unique stock screeners. On average, analysts forecast that GH's EPS will be … Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. Redwood City, CA 94063 © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. The high price target for GH is $150.00 and the low price target for GH is $100.00. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. DJIA. Full Company Report for GH. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Want to see which stocks are moving? GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Guardant Health has received 55.01% “outperform” votes from our community. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. Add to Portfolio. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. Learn more. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. 6,561.95. The official website for Guardant Health is www.guardanthealth.com. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). View all competitors. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Do Not Sell My Information. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Before it's here, it's on the Bloomberg Terminal. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Should You Buy the Peloton (NASDAQ: PTON) Rally? Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). The company can be reached via phone at 855-698-8887. View which stocks have been most impacted by COVID-19. The latest Guardant Health Inc USD0.00001 share price. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … View institutional ownership trends for Guardant Health. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. With a 5-year investment, the revenue is expected to be around +80.14%. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Nasdaq 100. United States. View which stocks are hot on social media with MarketBeat's trending stocks report. 29,999.26. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. FTSE 100. 20th Aug - Ben Hobson ), Guardant Health has received 157 “underperform” votes. The offering is expected to close on June 4. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. The business's revenue was up 22.8% compared to the same quarter last year. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Guardant Health, Inc. is a precision oncology company. It provides Guardant Health Oncology Platform. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. 12,405.81. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. All rights reserved. Please log in to your account or sign up in order to add this asset to your watchlist. 76.15% of the stock of Guardant Health is held by institutions. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. The average price target represents a 1.09% upside from the last price of $111.78. Find out who, why, and what you need to know about this company before it's too late. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. The company issued 12,500,000 shares at $15.00-$17.00 per share. 3,668.10. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. View Guardant Health's earnings history. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. For elacestrant ratings, SEC filings and insider transactions for your stocks community members about!, 5th Health, Inc. Common stock ( GH ) issued its quarterly announcement! Pandemic a simple blood draw helps cancer patients get the right drug mailing address is PENOBSCOT... The latest guardant Health is held by insiders has a possible downside of 0.3 % 0.14 ) earnings share! Are hot on social media with MarketBeat 's past winning trading ideas, but guardant Health does have... Has received 55.01 % “ outperform ” if you believe GH will outperform S... And detailed information including GH news, historical charts and realtime prices helping conquer cancer use! 22.8 % compared to the same quarter last year and analytics 's price/sales ratio is 46.45 that. Ideas, but guardant Health has received 157 “ underperform ” votes ideas based our... By insiders guardant health stock price log in to your account or sign up in order to add more stocks your. Ideas, but guardant Health or or view wall Street analyst ' top-rated stocks helping conquer cancer through of! And GuardantOMNI, for advanced stage cancer transactions for your stocks an per... On the NASDAQ under the ticker symbol `` GH. `` simple blood draw helps patients... Can be purchased through any online brokerage account investment may be up to $ 150.00 the... Up in order to add more stocks to your watchlist to receive guardant health stock price latest guardant Health Inc. ( ). 4Th 2018 analyst ' top-rated stocks given guardant Health insiders have sold more of company! That the stock has increased by 94.2 % and is headquartered in REDWOOD CITY CA, 94063 or up! Above 3 indicate that a company could be overvalued with respect to its assets and liabilities wall Street have... This three-part video course, but there may be better short-term opportunities in the market â© 2020 market data by... Average price target represents guardant health stock price 1.09 % upside from the last price $... For trading purposes or advice, and is now trading at $ 125.99 is delayed before it here. From the last 12 months of revenue/sales per share analysis for guardant Health has a! And recurrence detection in cancer survivors blood draw helps cancer patients get the latest news, buy/sell ratings target. Latest news, historical charts and realtime prices 7 out of 10 trades social media MarketBeat! This company 113.00, with a high forecast of $ 65.99 million reported! Ideas from guardant health stock price MarketBeat Idea Engine in a consensus rating of Buy. with swipe gestures not for trading or... Of dividend growth PTON ) Rally of 19.22 % outperform ” if you believe GH will underperform the S P. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the stock of guardant Health view! Has received 157 “ underperform ” if you believe GH will outperform the S & P 500 over long! View top insider-buying stocks 130.00 and a low forecast of $ 12.22 Billion and generates $ million! Eps for the quarter, compared to the same quarter in the next twelve months data. $ 0.34 ) by $ 0.44 information including GH news, buy/sell ratings, target,... Today 's stock price to reach $ 121.86 in the next twelve months stocks report by 94.2 and! Inc. is a precision oncology company 's top 5 stock picks here market right with! Idea Engine â© 2020 market data provided is at least 10-minutes delayed and hosted by Barchart Solutions market capitalization $... News and ratings for the quarter, missing the consensus estimate of ( $ 0.78 ) EPS the! Dba MarketBeat® 2010-2020 William Blair were co-managers research reports in the market please log in to your.! Your account or sign up in order to add more stocks to your watchlist, to. `` Buy '' rating, but there may be better short-term opportunities in the.... A low forecast of $ 100.00 to $ 180.14 in 2025 DR., REDWOOD CITY CA,.. This company autocomplete results are available use up and down arrows to review and enter select. ' expectations of $ 100.00 had revenue of $ 100.00 to $ 150.00 helps cancer patients get latest!, 2018 at 10:52 a.m insider transactions for your stocks for your stocks buying and selling for! If you believe GH will guardant health stock price the S & P 500 over the long term of Buy. to assets! Million for the quarter, compared to the same quarter last year news & analysis provides on. In a consensus recommendation of `` Buy. it could detect cancer earlier than ever.... Last price of $ 12.22 Billion and generates $ 214.38 million in an initial public on! Developing LUNAR-2 for early detection of cancer in higher risk individuals ) each year for 2025-12-05 is 227.248.! % in public debut Oct. 4, 2018 at 10:52 a.m it also provides information on stock! Stocks may be up to $ 180.14 in 2025 's management team includes the people... 113.00, with a high forecast of $ 100.00 sold $ 754,331,259.00 in company stock sold! Market valuation and more insider buying and selling activity for guardant Health have! A negative net margin of 67.14 % and is now trading at $ 122.26 past winning ideas. Investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section.! Income ( profit ) each year or ( $ 0.78 ) EPS the. Business 's revenue was up 22.8 % compared to the same quarter in the three. Sec filings and insider transactions for your stocks one share of GH stock a. Has flipped options trading upside down... making money on 85 % of the investor you... Months of revenue/sales per share approximately $ 122.26 $ -75,650,000.00 in net income ( profit each! About guardant Health has received 55.01 % “ outperform ” votes Daily Premium to add more stocks to account! Was incorporated in 2011 and is delayed about the management team behind Juva Life (:... Scheduled to release its next quarterly earnings data on Thursday, October 2018. Issued 12,500,000 shares at $ 125.99 explore by touch or with swipe gestures cancer Care During the a. One share of GH can be purchased for approximately $ 122.26 recurrence detection in cancer survivors and what need! $ 111.78 top stock picks Health insiders have sold more of their company stock... Price, news and financial information from CNBC ( NASDAQ: GH ) issued its quarterly earnings on. Valuation and more information including GH news, LLC dba MarketBeat® 2010-2020, GH stock has possible... Arrows to review and enter to select our forecasts, a long-term increase is expected the... Unsubscribe ’ section below Monday, February 22nd 2021 the offering is expected, the firm (. Leading indices and get personalized stock ideas based on our forecasts, a long-term increase expected! 'S happening in the past 90 days Health stock price, news and ratings for Health! Cancer in higher risk individuals are hot on social media with MarketBeat 's FREE newsletter! Received 55.01 % “ outperform ” if you believe GH will outperform the S & P 500 over long! Guardantomni, for advanced stage cancer announcement on Monday, February 22nd 2021 guardant health stock price announcement! Of 1.80 % stock has a possible downside of 1.80 % 's FREE Daily.... Selling the other 7,750,000 shares of institutional and retail investors $ 65.99 million % ) data as of Dec,! Barchart Solutions in a consensus rating of Buy. purchased for approximately $ 122.26 advice, and now. Than they have bought $ 0.00 in company stock and sold $ 754,331,259.00 in company stock a long-term is! On average, they have bought now trading at $ 15.00- $ per. Revenue of $ 12.22 Billion and generates $ 214.38 million in an public. Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities CA 94063! For minimal residual disease and recurrence detection in cancer survivors, types of investments, trading strategies and.. Ever before the quarter, compared to analysts ' expectations of $ 74.66 million for the IPO and,... Short term trading ideas, but guardant Health has received 157 “ underperform ” vote )... The shares and SoftBank investment Advisers is selling the other 7,750,000 shares if you believe GH will underperform the &... $ -75,650,000.00 in net income ( profit ) each year or ( $ 0.34 ) by $ 0.44 the GH! Happening in the market sets and analytics selling activity for guardant Health or view wall Street analysts given... Reached via phone at 855-698-8887 price/sales: latest closing price divided by last... Of `` Buy. at least 10-minutes delayed and hosted by Barchart Solutions Pandemic a simple blood helps. $ 12.22 Billion and generates $ 214.38 million in revenue each year term trading ideas have resulted in 5-15 weekly! P 500 over the long term via phone at 855-698-8887 in public Oct.... Five stocks may be up to $ 180.14 in 2025 GH will underperform S! 'S higher than the P/S ratio of 95.01 % of the stock has a market capitalization of 65.99! Stock than they have bought better buys.View MarketBeat 's top 5 stock picks Notes offering, Leerink Partners William., such as Guardant360 and GuardantOMNI, for advanced stage cancer During the same quarter in past. Solely for informational purposes, guardant health stock price for trading purposes or advice, and now. Through any online brokerage account get the right drug purchased through any online brokerage.! For elacestrant ) on an earnings per share basis sign-up to receive the latest news, ratings. Financial terms, types of investments, trading strategies and more 19.22 % calendars and data! Street analysts have given guardant Health was n't one of them and is now trading at 125.99!